OK, the naysayers are going to get really grumpy again. Oh well....
Lets assume POH has to raise the full $35 million to fully complete the Oxypatch onto market in 2014/15. Lets assume it is at the terrible 13c SCE put in their research. Another 250,000,000 shares in round figures. Making POH have roughly 1 Billion shares on issue.
I'll assume that Elixia and other projects cover ALL other POH costs in this period, for simplicity.
So POH could successfully complete phase 3 trials on Oxypatch in as little as 6-9 months. Q1 2012.
What is this Oxypatch worth once finished and on market in 2014/15? $1.5 billion per year to POH?
The above scenario is very plausible based on current info.
What would a realistic takeover offer be, when phase 3 is successfully completed in 6-9 months???????
Thoughts??
OK, the naysayers are going to get really grumpy again. Oh...
Add AVE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
0.001(50.0%) |
Mkt cap ! $9.507M | |||
| Open | High | Low | Value | Volume |
| 0.3¢ | 0.3¢ | 0.3¢ | $1.783K | 594.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 60 | 96365901 | 0.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.3¢ | 21872826 | 7 |
View Market Depth
| Last trade - 16.10pm 11/07/2024 (20 minute delay) ? |
| AVE (ASX) Chart |